Literature DB >> 23148629

Bladder cancer pharmacogenomics: recent insights and future perspectives.

Peter H O'Donnell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23148629     DOI： 10.2217/pgs.12.145

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  3 in total

1.  Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.

Authors:  Peter H O'Donnell; Shaheen Alanee; Kelly L Stratton; Ilana R Garcia-Grossman; Hongyuan Cao; Irina Ostrovnaya; Elizabeth R Plimack; Christopher Manschreck; Cory Ganshert; Norm D Smith; Gary D Steinberg; Joseph Vijai; Kenneth Offit; Walter M Stadler; Dean F Bajorin
Journal:  Clin Genitourin Cancer       Date:  2016-03-10       Impact factor: 2.872

Review 2.  Pharmacogenomics in bladder cancer.

Authors:  Garrett M Dancik; Dan Theodorescu
Journal:  Urol Oncol       Date:  2014-01       Impact factor: 3.498

3.  Diagnostic Microdosing Approach to Study Gemcitabine Resistance.

Authors:  Tiffany M Scharadin; Hongyong Zhang; Maike Zimmermann; Sisi Wang; Michael A Malfatti; George D Cimino; Kenneth Turteltaub; Ralph de Vere White; Chong-Xian Pan; Paul T Henderson
Journal:  Chem Res Toxicol       Date:  2016-10-10       Impact factor: 3.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.